Literature DB >> 2891083

Brain glutamate deficiency in amyotrophic lateral sclerosis.

T L Perry1, S Hansen, K Jones.   

Abstract

Amino acid contents were measured in autopsied brains of eight patients with the sporadic form of amyotrophic lateral sclerosis (ALS) and in brains of control subjects dying without neurologic or psychiatric disease. Glutamic acid content was reduced in most brain regions and in the cervical cord in the ALS patients, while glutamine contents were normal. Taurine contents were increased, and gamma-aminobutyric acid contents were decreased in some brain regions in the ALS patients. The brain glutamate deficiency in ALS is unexplained, but insufficient production or release of this excitatory neurotransmitter might have important secondary effects on motor neurons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891083     DOI: 10.1212/wnl.37.12.1845

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.

Authors:  O Blin; J Pouget; G Aubrespy; C Guelton; A Crevat; G Serratrice
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.

Authors:  M B Yim; J H Kang; H S Yim; H S Kwak; P B Chock; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Levels of amino acids in 52 discrete areas of postmortem brain of adult and aged humans.

Authors:  M Banay-Schwartz; M Palkovits; A Lajtha
Journal:  Amino Acids       Date:  1993-06       Impact factor: 3.520

Review 4.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

5.  Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.

Authors:  K Chida; S Sakamaki; T Takasu
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

6.  Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

Authors:  S Malessa; P N Leigh; O Bertel; E Sluga; O Hornykiewicz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

7.  Heterogeneous distribution of functionally important amino acids in brain areas of adult and aging humans.

Authors:  M Banay-Schwartz; M Palkovits; A Lajtha
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

8.  Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis.

Authors:  D Testa; T Caraceni; V Fetoni
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

9.  Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis.

Authors:  Michaeline Hebron; Wenqiang Chen; Matthew J Miessau; Irina Lonskaya; Charbel E-H Moussa
Journal:  J Neurochem       Date:  2013-12-19       Impact factor: 5.372

10.  Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients.

Authors:  K Nihei; A C McKee; N W Kowall
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.